false
0001840317
0001840317
2026-01-14
2026-01-14
0001840317
VEEA:CommonStockParValue0.0001PerShareMember
2026-01-14
2026-01-14
0001840317
VEEA:WarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember
2026-01-14
2026-01-14
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
January 20, 2026 (January 14, 2026)
| Veea Inc. |
| (Exact name of registrant as specified in its charter) |
| Delaware |
|
001-40218 |
|
98-1577353 |
|
(State or other Jurisdiction
of Incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
164 E. 83rd Street
New York, NY 10028
(212) 535-6050
(Address and telephone number, including area code,
of registrant’s principal executive offices)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b)
of the Act:
| Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Common stock, par value $0.0001 per share |
|
VEEA |
|
The Nasdaq Stock Market LLC |
| Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per share |
|
VEEAW |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 1.01 Entry into a Material Definitive Agreement.
Note Purchase Agreement
On January 14, 2026, Veea Inc., a Delaware
corporation (the “Company” and White Lion Capital, LLC, a Nevada limited liability company (“White
Lion”) entered into a Note Purchase Agreement (the “Note Purchase Agreement”). Pursuant to the
Note Purchase Agreement, the Company agreed to issue, and White Lion agreed to purchase, at one or more closings, on the terms and
conditions contained in the Note Purchase Agreement, unsecured promissory notes in the aggregate funded amount of up to $2,500,000
(the “Convertible Notes”) and common stock warrants (the “Warrants” and collectively
with the Convertible Notes, the “Securities”) to purchase shares of the Company’s common stock, par value
$0.0001 per share (“Common Stock”). The first closing occurred on January 14, 2026 (the “First
Closing”) at which the Company issued, and White Lion purchased, a Convertible Note with a face amount of $555,556 and Warrant
to purchase 990,099 shares of Common Stock (the “Warrant Shares”) with an exercise price of $0.505 per share. At
the First Closing, the Company received cash proceeds of $475,000, net of original issuance discount and certain transaction
expenses.
The Convertible Notes mature 12-months from the
date of issuance and accrue interest at an annual rate of five (5) percent per annum. The Convertible Notes are convertible, in whole
or in part, into shares of Common Stock (the “Conversion Shares”) at the option of White Lion, at a price per
share equal to the lesser of (i) $0.75 per share and (ii) 90% of the lowest VWAP (calculated as set forth in the Convertible Notes) for
the prior consecutive ten (10) trading-day period, in each case subject to certain equitable adjustments. The Convertible Notes contain
ownership limitations pursuant to which White Lion does not have the right to exercise any portion of its Convertible Notes if it would
result in White Lion (together with its affiliates) beneficially owning more than 4.99% (or, at the election of White Lion, 9.99%) of
the outstanding Common Stock. The Convertible Notes are repayable by the Company at any time, in whole or in part, without premium or
penalty, other than the Convertible Note issued at the First Closing. Upon an event of default, the outstanding principal amount of the
outstanding Convertible Notes, plus accrued but unpaid interest will become immediately due and payable in full. Events of default include,
among others, failure to pay any principal or interest amounts under the Convertible Notes, failure to perform covenants in the Convertible
Notes and certain bankruptcy and insolvency conditions of the Company.
Under the terms of the Note Purchase Agreement,
the Company agreed to sell at each closing, in addition to a Convertible Note one accompanying Warrant at a price per share equal to
the Common Stock’s closing price on such closing date, subject to certain adjustments. The Warrants expire five years from the date
of issuance. The Warrants contain ownership limitations pursuant to which White Lion does not have the right to exercise any portion of
their Warrants if it would result in White Lion (together with its affiliates) beneficially owning more than 4.99% (or, at the election
of White Lion, 9.99%) of the outstanding Common Stock. The Company may elect, by written notice to White Lion, (the “Call Notice”),
to cause White Lion to exercise its unexercised Warrants, at the then effective exercise price, at any time that (i) all Warrant Shares
are fully registered for resale pursuant to an effective registration statement and (ii) the closing price of the Common Stock has been
greater than $3.00 per share for at least thirty (30) consecutive trading days preceding the date of the Call Notice.
Concurrently with the Note Purchase Agreement,
the Company entered into a related Registration Rights Agreement (the “RRA”) with White Lion, pursuant to which the Company
agreed to file, within 60 days following the First Closing, a Registration Statement with the Securities and Exchange Commission covering
the resale by White Lion of the number of the Conversion Shares and the Warrant Shares. The RRA also contains usual and customary damages
provisions for failure to file and failure to have the Registration Statement declared effective by the SEC within the time periods specified
therein.
The Note Purchase Agreement, the Convertible Notes,
the Warrants and the Registration Rights Agreement include other customary terms and conditions. The above description of the Warrants,
Note Purchase Agreement, the Convertible Notes, and the Registration Rights Agreement are qualified in their entirety by the text of the
Form of Warrant, the Note Purchase Agreement, Form of Convertible Note, and Registration Rights Agreement copies of which are attached
as Exhibits 4.1, 10.1, 10.2, and 10.03, respectively, to this Current Report on Form 8-K and incorporated herein by reference.
Amendment to Existing ELOC Agreement
On January 14, 2026, the Company and White Lion
entered into an amendment (the “ELOC Amendment”) to the Common Stock Purchase Agreement dated December 2, 2024 (as
amended, the “ELOC Purchase Agreement”). Pursuant to the ELOC Amendment, (a) the commitment period for sales of shares
of Common Stock to White Lion was extended from December 2, 2026 to June 30, 2027 and (b) the Company agreed to issue additional shares
of Common Stock to White Lion in consideration for its commitment in amounts equal to (i) $25,000 at the time of the ELOC Amendment, (ii)
$50,000, if the Company has not sold to White Lion under the ELOC Purchase Agreement an aggregate of $1,250,000 in gross proceeds of Common
Stock through April 15, 2026, (iii) $25,000, if the Company has not sold to White Lion under the ELOC Purchase Agreement an aggregate
of $1,500,000 in gross proceeds of Common Stock through June 30, 2026. The number of shares of Common Stock issued in each instance is
determined by dividing the dollar value of the shares of Common Stock to be issued by the average VWAP of the Common Stock for the ten-day
trading period immediately prior to the issuance date.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation
under an Off-Balance Sheet Arrangement of a Registrant.
The information set forth above under Item 1.01 of this Current
Report on Form 8-K with respect to the issuance of the Convertible Notes is hereby incorporated by reference into this Item 2.03.
Item 3.02 Unregistered Sales of Equity Securities.
The information contained above under Item 1.01, to the extent applicable,
is hereby incorporated by reference herein. Based in part upon the representations of White Lion in the Note Purchase Agreement, the issuance
and sale of Convertible Notes and the Warrants was made in a private placement transaction exempt for registration in reliance on the
exemption afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”).
The offer and sale of the Securities, the issuance
of the Conversion Shares and the issuance of the Warrant Shares have not been registered under the Securities Act or any state securities
laws. The Common Stock may not be offered or sold in the United States absent registration or an applicable exemption from registration
requirements. Neither this Current Report on Form 8-K, nor the exhibits attached hereto, is an offer to sell or the solicitation of an
offer to buy the Common Stock described herein or therein. Neither this Current Report on Form 8-K nor any exhibit attached hereto is
an offer to sell or the solicitation of an offer to buy shares of Common Stock or other securities of the Company.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. The following
exhibits are filed with this Form 8-K:
Exhibit
Number |
|
Description |
| 4.1* |
|
Form of Warrant |
| 10.01* |
|
Note Purchase Agreement dated January 14, 2026 |
| 10.02* |
|
Form of Convertible Note |
| 10.03* |
|
Registration Rights Agreement dated January 14, 2026 |
| 104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |
Veea Inc. |
| |
|
|
| Date: January 20, 2026 |
By: |
/s/ Allen Salmasi |
| |
Name: |
Allen Salmasi |
| |
Title: |
Chief Executive Officer |